ArticleJACC. Case reports2026
Catheter-Based Renal Denervation in Acute Type B Aortic Dissection to Optimize Long-Term Pressure Control.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Aortic Sealing: Integrating Anatomy and Physiology in Type B Aortic Dissection.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRefractory hypertension (RH) is a critical complication of type B aortic dissection (TBAD) in acute and chronic phases. Adequate long-term pressure control reduces aortic-related adverse events, yet approximately 40% of patients do not achieve optimal therapeutic goals. Renal denervation (RDN) is an established technique used for chronic RH, but no experiences are reported in acute TBAD. FIRST-IN-HUMAN: The current series presents the first-in-human experience of RDN in acute TBAD: 2 patients were treated with thoracic endovascular aortic repair because of RH. RDN was performed as an adjunctive procedure to optimize long-term pressure control. Both procedures were successful. At the 3-month follow-up, the patients experienced satisfactory blood pressure control with a reduced antihypertensive regimen. TAKE-HOME MESSAGES: RDN is a feasible adjunctive tool for achieving sustained blood pressure control in acute TBAD. Larger prospective studies are needed to confirm its safety and efficacy and its impact on long-term aortic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.